These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24900758)

  • 1. Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
    Gehling VS; Hewitt MC; Vaswani RG; Leblanc Y; Côté A; Nasveschuk CG; Taylor AM; Harmange JC; Audia JE; Pardo E; Joshi S; Sandy P; Mertz JA; Sims RJ; Bergeron L; Bryant BM; Bellon S; Poy F; Jayaram H; Sankaranarayanan R; Yellapantula S; Bangalore Srinivasamurthy N; Birudukota S; Albrecht BK
    ACS Med Chem Lett; 2013 Sep; 4(9):835-40. PubMed ID: 24900758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC).
    Zhang M; Zhang Y; Song M; Xue X; Wang J; Wang C; Zhang C; Li C; Xiang Q; Zou L; Wu X; Wu C; Dong B; Xue W; Zhou Y; Chen H; Wu D; Ding K; Xu Y
    J Med Chem; 2018 Apr; 61(7):3037-3058. PubMed ID: 29566488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors.
    Bennett MJ; Wu Y; Boloor A; Matuszkiewicz J; O'Connell SM; Shi L; Stansfield RK; Del Rosario JR; Veal JM; Hosfield DJ; Xu J; Kaldor SW; Stafford JA; Betancort JM
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1811-1816. PubMed ID: 29657099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).
    Seal J; Lamotte Y; Donche F; Bouillot A; Mirguet O; Gellibert F; Nicodeme E; Krysa G; Kirilovsky J; Beinke S; McCleary S; Rioja I; Bamborough P; Chung CW; Gordon L; Lewis T; Walker AL; Cutler L; Lugo D; Wilson DM; Witherington J; Lee K; Prinjha RK
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2968-72. PubMed ID: 22437115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains.
    Millan DS; Kayser-Bricker KJ; Martin MW; Talbot AC; Schiller SER; Herbertz T; Williams GL; Luke GP; Hubbs S; Alvarez Morales MA; Cardillo D; Troccolo P; Mendes RL; McKinnon C
    ACS Med Chem Lett; 2017 Aug; 8(8):847-852. PubMed ID: 28835800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased multicomponent reactions to develop novel bromodomain inhibitors.
    McKeown MR; Shaw DL; Fu H; Liu S; Xu X; Marineau JJ; Huang Y; Zhang X; Buckley DL; Kadam A; Zhang Z; Blacklow SC; Qi J; Zhang W; Bradner JE
    J Med Chem; 2014 Nov; 57(21):9019-27. PubMed ID: 25314271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-Based Drug Discovery in the Bromodomain and Extra-Terminal Domain Family.
    Radwan M; Serya R
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28714212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.
    Bamborough P; Diallo H; Goodacre JD; Gordon L; Lewis A; Seal JT; Wilson DM; Woodrow MD; Chung CW
    J Med Chem; 2012 Jan; 55(2):587-96. PubMed ID: 22136469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of methyl isoxazoleazepines as inhibitors of BET.
    Hewitt MC; Leblanc Y; Gehling VS; Vaswani RG; Côté A; Nasveschuk CG; Taylor AM; Harmange JC; Audia JE; Pardo E; Cummings R; Joshi S; Sandy P; Mertz JA; Sims RJ; Bergeron L; Bryant BM; Bellon S; Poy F; Jayaram H; Tang Y; Albrecht BK
    Bioorg Med Chem Lett; 2015 May; 25(9):1842-8. PubMed ID: 25851940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain.
    Law RP; Atkinson SJ; Bamborough P; Chung CW; Demont EH; Gordon LJ; Lindon M; Prinjha RK; Watson AJB; Hirst DJ
    J Med Chem; 2018 May; 61(10):4317-4334. PubMed ID: 29656650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors.
    Wang L; Pratt JK; Soltwedel T; Sheppard GS; Fidanze SD; Liu D; Hasvold LA; Mantei RA; Holms JH; McClellan WJ; Wendt MD; Wada C; Frey R; Hansen TM; Hubbard R; Park CH; Li L; Magoc TJ; Albert DH; Lin X; Warder SE; Kovar P; Huang X; Wilcox D; Wang R; Rajaraman G; Petros AM; Hutchins CW; Panchal SC; Sun C; Elmore SW; Shen Y; Kati WM; McDaniel KF
    J Med Chem; 2017 May; 60(9):3828-3850. PubMed ID: 28368119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.
    Flynn NR; Ward MD; Schleiff MA; Laurin CMC; Farmer R; Conway SJ; Boysen G; Swamidass SJ; Miller GP
    Metabolites; 2021 Jun; 11(6):. PubMed ID: 34203690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 8-Methyl-pyrrolo[1,2-
    Li Z; Xiao S; Yang Y; Chen C; Lu T; Chen Z; Jiang H; Chen S; Luo C; Zhou B
    J Med Chem; 2020 Apr; 63(8):3956-3975. PubMed ID: 32208600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation.
    Xue X; Zhang Y; Liu Z; Song M; Xing Y; Xiang Q; Wang Z; Tu Z; Zhou Y; Ding K; Xu Y
    J Med Chem; 2016 Feb; 59(4):1565-79. PubMed ID: 26731490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization.
    Zhao L; Wang Y; Cao D; Chen T; Wang Q; Li Y; Xu Y; Zhang N; Wang X; Chen D; Chen L; Chen YL; Xia G; Shi Z; Liu YC; Lin Y; Miao Z; Shen J; Xiong B
    J Med Chem; 2015 Feb; 58(3):1281-97. PubMed ID: 25559428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor.
    Sperandio D; Aktoudianakis V; Babaoglu K; Chen X; Elbel K; Chin G; Corkey B; Du J; Jiang B; Kobayashi T; Mackman R; Martinez R; Yang H; Zablocki J; Kusam S; Jordan K; Webb H; Bates JG; Lad L; Mish M; Niedziela-Majka A; Metobo S; Sapre A; Hung M; Jin D; Fung W; Kan E; Eisenberg G; Larson N; Newby ZER; Lansdon E; Tay C; Neve RM; Shevick SL; Breckenridge DG
    Bioorg Med Chem; 2019 Feb; 27(3):457-469. PubMed ID: 30606676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.
    Shimamura T; Chen Z; Soucheray M; Carretero J; Kikuchi E; Tchaicha JH; Gao Y; Cheng KA; Cohoon TJ; Qi J; Akbay E; Kimmelman AC; Kung AL; Bradner JE; Wong KK
    Clin Cancer Res; 2013 Nov; 19(22):6183-92. PubMed ID: 24045185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer.
    Xue X; Zhang Y; Wang C; Zhang M; Xiang Q; Wang J; Wang A; Li C; Zhang C; Zou L; Wang R; Wu S; Lu Y; Chen H; Ding K; Li G; Xu Y
    Eur J Med Chem; 2018 May; 152():542-559. PubMed ID: 29758518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.
    Sharp PP; Garnier JM; Hatfaludi T; Xu Z; Segal D; Jarman KE; Jousset H; Garnham A; Feutrill JT; Cuzzupe A; Hall P; Taylor S; Walkley CR; Tyler D; Dawson MA; Czabotar P; Wilks AF; Glaser S; Huang DCS; Burns CJ
    ACS Med Chem Lett; 2017 Dec; 8(12):1298-1303. PubMed ID: 29259751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains.
    Taylor AM; Vaswani RG; Gehling VS; Hewitt MC; Leblanc Y; Audia JE; Bellon S; Cummings RT; Côté A; Harmange JC; Jayaram H; Joshi S; Lora JM; Mertz JA; Neiss A; Pardo E; Nasveschuk CG; Poy F; Sandy P; Setser JW; Sims RJ; Tang Y; Albrecht BK
    ACS Med Chem Lett; 2016 Feb; 7(2):145-50. PubMed ID: 26985289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.